1038 related articles for article (PubMed ID: 27879219)
1. Induced pluripotent stem cells (iPSCs) derived from cerebrotendinous xanthomatosis (CTX) patient's fibroblasts carrying a R395S mutation.
Höflinger P; Hauser S; Theurer Y; Weißenberger S; Wilke C; Schöls L
Stem Cell Res; 2016 Sep; 17(2):433-436. PubMed ID: 27879219
[TBL] [Abstract][Full Text] [Related]
2. Generation of induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia patient carrying a homozygous Y275X mutation in CYP7B1 (SPG5).
Hauser S; Höflinger P; Theurer Y; Rattay TW; Schöls L
Stem Cell Res; 2016 Sep; 17(2):437-440. PubMed ID: 27879220
[TBL] [Abstract][Full Text] [Related]
3. Generation of induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia patient carrying a homozygous R486C mutation in CYP7B1 (SPG5).
Höflinger P; Theurer Y; Schüle R; Schöls L; Hauser S
Stem Cell Res; 2016 Sep; 17(2):422-425. PubMed ID: 27879216
[TBL] [Abstract][Full Text] [Related]
4. Generation of induced pluripotent stem cells (iPSCs) from a retinoblastoma patient carrying a c.2663G>A mutation in RB1 gene.
Zeng S; Liu L; Ouyang Q; Zhao Y; Lin G; Hu L; Li W
Stem Cell Res; 2016 Sep; 17(2):208-211. PubMed ID: 27879208
[TBL] [Abstract][Full Text] [Related]
5. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
[TBL] [Abstract][Full Text] [Related]
6. Peripheral blood derived induced pluripotent stem cells (iPSCs) from a female with familial hypertrophic cardiomyopathy.
Ross SB; Fraser ST; Bagnall RD; Semsarian C
Stem Cell Res; 2017 Apr; 20():76-79. PubMed ID: 28395744
[TBL] [Abstract][Full Text] [Related]
7. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a L150P mutation in PSEN-1.
Tubsuwan A; Pires C; Rasmussen MA; Schmid B; Nielsen JE; Hjermind LE; Hall V; Nielsen TT; Waldemar G; Hyttel P; Clausen C; Kitiyanant N; Freude KK; Holst B
Stem Cell Res; 2016 Jan; 16(1):110-2. PubMed ID: 27345792
[TBL] [Abstract][Full Text] [Related]
8. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying an A79V mutation in PSEN1.
Li T; Pires C; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Dinnyes A; Hyttel P; Freude KK
Stem Cell Res; 2016 Mar; 16(2):229-32. PubMed ID: 27345973
[TBL] [Abstract][Full Text] [Related]
9. Generation of optic atrophy 1 patient-derived induced pluripotent stem cells (iPS-OPA1-BEHR) for disease modeling of complex optic atrophy syndromes (Behr syndrome).
Hauser S; Schuster S; Theurer Y; Synofzik M; Schöls L
Stem Cell Res; 2016 Sep; 17(2):426-429. PubMed ID: 27879217
[TBL] [Abstract][Full Text] [Related]
10. Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.B11.
Hansen SK; Borland H; Hasholt LF; Tümer Z; Nielsen JE; Rasmussen MA; Nielsen TT; Stummann TC; Fog K; Hyttel P
Stem Cell Res; 2016 May; 16(3):589-92. PubMed ID: 27346191
[TBL] [Abstract][Full Text] [Related]
11. Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.A11.
Hansen SK; Borland H; Hasholt LF; Tümer Z; Nielsen JE; Rasmussen MA; Nielsen TT; Stummann TC; Fog K; Hyttel P
Stem Cell Res; 2016 May; 16(3):553-6. PubMed ID: 27346190
[TBL] [Abstract][Full Text] [Related]
12. Establishment of SPAST mutant induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia (HSP) patient.
Hauser S; Erzler M; Theurer Y; Schuster S; Schüle R; Schöls L
Stem Cell Res; 2016 Nov; 17(3):485-488. PubMed ID: 27789400
[TBL] [Abstract][Full Text] [Related]
13. Episomal plasmid-based generation of an iPSC line from a 79-year-old individual carrying the APOE4/4 genotype: i11001.
Zulfiqar S; Fritz B; Nieweg K
Stem Cell Res; 2016 Nov; 17(3):544-546. PubMed ID: 27789405
[TBL] [Abstract][Full Text] [Related]
14. Episomal plasmid-based generation of an iPSC line from an 83-year-old individual carrying the APOE4/4 genotype: i10984.
Zulfiqar S; Fritz B; Nieweg K
Stem Cell Res; 2016 Nov; 17(3):523-525. PubMed ID: 27789402
[TBL] [Abstract][Full Text] [Related]
15. Generation of induced pluripotent stem cell line (ZZUi007-A) from a 52-year-old patient with a novel CHCHD2 gene mutation in Parkinson's disease.
Wang Y; Wang Z; Sun H; Mao C; Yang J; Liu Y; Liu H; Zhang S; Zhang J; Xu Y; Shi C
Stem Cell Res; 2018 Oct; 32():87-90. PubMed ID: 30237140
[TBL] [Abstract][Full Text] [Related]
16. Generation of human iPSCs from an essential thrombocythemia patient carrying a V501L mutation in the MPL gene.
Liu S; Ye Z; Gao Y; He C; Williams DW; Moliterno A; Spivak J; Huang H; Cheng L
Stem Cell Res; 2017 Jan; 18():57-59. PubMed ID: 28395806
[TBL] [Abstract][Full Text] [Related]
17. Reactivation of Endogenous Genes and Epigenetic Remodeling Are Barriers for Generating Transgene-Free Induced Pluripotent Stem Cells in Pig.
Choi KH; Park JK; Son D; Hwang JY; Lee DK; Ka H; Park J; Lee CK
PLoS One; 2016; 11(6):e0158046. PubMed ID: 27336671
[TBL] [Abstract][Full Text] [Related]
18. Lymphoblast-derived integration-free iPS cell line from a 65-year-old Alzheimer's disease patient expressing the TREM2 p.R47H variant.
Schröter F; Sleegers K; Cuyvers E; Bohndorf M; Wruck W; Van Broeckhoven C; Adjaye J
Stem Cell Res; 2016 Jan; 16(1):113-5. PubMed ID: 27345793
[TBL] [Abstract][Full Text] [Related]
19. Generation of HEXA-deficient hiPSCs from fibroblasts of a Tay-Sachs disease patient.
Liu Z; Zhao R
Stem Cell Res; 2016 Sep; 17(2):289-291. PubMed ID: 27879213
[TBL] [Abstract][Full Text] [Related]
20. Cerebrotendinous xanthomatosis with a compound heterozygote mutation and severe polyneuropathy.
Wang Z; Yuan Y; Zhang W; Zhang Y; Feng L
Neuropathology; 2007 Feb; 27(1):62-6. PubMed ID: 17319284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]